Cargando…

T cell receptor gene‐modified allogeneic T cells with siRNA for endogenous T cell receptor induce efficient tumor regression without graft‐versus‐host disease

Adoptive immunotherapy using genetically engineered patient‐derived lymphocytes to express tumor‐reactive receptors is a promising treatment for malignancy. However, utilization of autologous T cells in this therapy limits the quality of gene‐engineered T cells, thereby inhibiting the timely infusio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okada, Satomi, Muraoka, Daisuke, Yasui, Kiyoshi, Tawara, Isao, Kawamura, Ayumi, Okamoto, Sachiko, Mineno, Junichi, Seo, Naohiro, Shiku, Hiroshi, Eguchi, Susumu, Ikeda, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637063/ https://www.ncbi.nlm.nih.gov/pubmed/37675556 http://dx.doi.org/10.1111/cas.15954

Ejemplares similares

Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression
por: Ikeda, Hiroaki, et al.
Publicado: (2014)

Systemic CD8(+) T Cell-Mediated Tumoricidal Effects by Intratumoral Treatment of Oncolytic Herpes Simplex Virus with the Agonistic Monoclonal Antibody for Murine Glucocorticoid-Induced Tumor Necrosis Factor Receptor
por: Ishihara, Mikiya, et al.
Publicado: (2014)

A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression
por: Okamoto, Sachiko, et al.
Publicado: (2012)

CD4(+) T cells support polyfunctionality of cytotoxic CD8(+) T cells with memory potential in immunological control of tumor
por: Imai, Naoko, et al.
Publicado: (2020)

CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy
por: Wang, Yizheng, et al.
Publicado: (2023)

A Functionally Superior Second-Generation Vector Expressing an Aurora Kinase-A-Specific T-Cell Receptor for Anti-Leukaemia Adoptive Immunotherapy
por: Casey, Nicholas Paul, et al.
Publicado: (2016)

Genetic engineering of T cells with receptors from NY-ESO-1-specific tumor-recognizing CD4+ T cell as a novel approach for adoptive T cell therapy
por: Matsuzaki, Junko, et al.
Publicado: (2015)

Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome
por: Wang, Linan, et al.
Publicado: (2016)

Co-Introduced Functional CCR2 Potentiates In Vivo Anti-Lung Cancer Functionality Mediated by T Cells Double Gene-Modified to Express WT1-Specific T-Cell Receptor
por: Asai, Hiroaki, et al.
Publicado: (2013)

Signal-transducing adaptor protein-2 promotes generation of functional long-term memory CD8(+) T cells by preventing terminal effector differentiation
por: Muraoka, Daisuke, et al.
Publicado: (2017)

αβ-T cell receptor transduction gives superior mitochondrial function to γδ-T cells with promising persistence
por: Ishihara, Mikiya, et al.
Publicado: (2023)

Feasibility of gene-immunotherapy using WT1-specific T-cell receptor gene transfer for infant acute lymphoblastic leukemia with MLL gene rearrangement
por: Nagai, K, et al.
Publicado: (2011)

Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses
por: Matsuzaki, Junko, et al.
Publicado: (2015)

Interleukin-17 Induces an Atypical M2-Like Macrophage Subpopulation That Regulates Intestinal Inflammation
por: Nishikawa, Kenichiro, et al.
Publicado: (2014)

T-cell receptor repertoire of cytomegalovirus-specific cytotoxic T-cells after allogeneic stem cell transplantation
por: Toya, Takashi, et al.
Publicado: (2020)

Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury
por: Asai, Hiroaki, et al.
Publicado: (2014)

Highly efficient genome editing for single-base substitutions using optimized ssODNs with Cas9-RNPs
por: Okamoto, Sachiko, et al.
Publicado: (2019)

Definition of target antigens for naturally occurring CD4(+) CD25(+) regulatory T cells
por: Nishikawa, Hiroyoshi, et al.
Publicado: (2005)

Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells
por: Sato, Osamu, et al.
Publicado: (2023)

Donor‐derived M2 macrophages attenuate GVHD after allogeneic hematopoietic stem cell transplantation
por: Hanaki, Ryo, et al.
Publicado: (2021)

Effect of Accessory Cells on Stimulation of Murine T‐Cell Leukemia with Antibodies to the CD3/T Cell Antigen Receptor Complex
por: Suto, Ryuichiro, et al.
Publicado: (1993)

Activated CD8(+) T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells
por: Seo, Naohiro, et al.
Publicado: (2018)

Genome-edited allogeneic donor “universal” chimeric antigen receptor T cells
por: Qasim, Waseem
Publicado: (2023)

Allogeneic transplantation of epidermal cell sheets followed by endoscopic submucosal dissection to prevent severe esophageal stricture in a porcine model
por: Kobayashi, Shinichiro, et al.
Publicado: (2022)

Features of repertoire diversity and gene expression in human cytotoxic T cells following allogeneic hematopoietic cell transplantation
por: Nakasone, Hideki, et al.
Publicado: (2021)

B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy
por: Migliaccio, Nunzia, et al.
Publicado: (2015)

Chemical augmentation of mitochondrial electron transport chains tunes T cell activation threshold in tumors
por: Dotsu, Yosuke, et al.
Publicado: (2022)

In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer
por: Ikeda, Hiroaki, et al.
Publicado: (2013)

NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome
por: Ishihara, Mikiya, et al.
Publicado: (2022)

A Comparison of the Physical Activity and Sedentary Behavior between Autologous and Allogeneic Hematopoietic Stem Cell Transplantation Survivors
por: Nakagami, Takayuki, et al.
Publicado: (2023)

Pertuzumab, trastuzumab and eribulin mesylate therapy for previously treated advanced HER2-positive breast cancer: a feasibility study with analysis of biomarkers
por: Tono, Yasutaka, et al.
Publicado: (2018)

HLA-DPB1 Reactive T Cell Receptors for Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation
por: Klobuch, Sebastian, et al.
Publicado: (2020)

Importance of killer immunoglobulin-like receptors in allogeneic hematopoietic stem cell transplantation
por: Franceschi, Danilo Santana Alessio, et al.
Publicado: (2011)

Exercise-Induced Oxidative Stress and the Effects of Antioxidant Intake from a Physiological Viewpoint
por: Kawamura, Takuji, et al.
Publicado: (2018)

The Cell Surface Receptor SLAM Controls T Cell and Macrophage Functions
por: Wang, Ninghai, et al.
Publicado: (2004)

Silencing of Tumor Necrosis Factor Receptor 1 by siRNA in EC109 Cells Affects Cell Proliferation and Apoptosis
por: Changhui, Ma, et al.
Publicado: (2009)

Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells
por: Kato, Taigo, et al.
Publicado: (2018)

P71. Adoptive transfer of TCR gene-transduced lymphocytes targeting MAGE-A4 for refractory esophageal cancer
por: Shiku, H, et al.
Publicado: (2014)

Autoantibodies against glutamate receptor δ2 after allogenic stem cell transplantation
por: Miske, Ramona, et al.
Publicado: (2016)

Clinical significance of T cell receptor excision circle (TREC) quantitation after allogenic HSCT
por: Mikhael, Neveen Lewis, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_anp0536n8ips64db94epqqc2ku